Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study

JD Herazo-Maya, J Sun, PL Molyneaux, Q Li… - The Lancet …, 2017 - thelancet.com
Background The clinical course of idiopathic pulmonary fibrosis (IPF) is unpredictable.
Clinical prediction tools are not accurate enough to predict disease outcomes. Methods We …

Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key …

KO Lindell, M Nouraie, MJ Klesen… - BMJ open …, 2018 - bmjopenrespres.bmj.com
Introduction Idiopathic pulmonary fibrosis (IPF), a progressive life-limiting lung disease
affects approximately 128 000 newly diagnosed individuals in the USA annually. IPF, a …